LNC THERAPEUTICS

lnc-therapeutics-logo

LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of โ‚ฌ 16.5 million raised so far including โ‚ฌ 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.

#SimilarOrganizations #People #Financial #Website #More

LNC THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Life Science

Founded:
2010-01-01

Address:
Bordeaux, Aquitaine, France

Country:
France

Website Url:
http://www.lnctherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
+33557831503

Email Addresses:
[email protected]

Total Funding:
19.09 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Amazon Facebook Sharer CloudFront Google Adsense AWS Global Accelerator


Similar Organizations

the-brkfst-club-logo

The Brkfst Club

The Brkfst Club focuses on gathering like-minded individuals to invest in ground breaking ideas.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Current Employees Featured

fabrice-guez_image

Fabrice Guez
Fabrice Guez CFO @ LNC Therapeutics
CFO
2010-01-01

sandrine-claus_image

Sandrine Claus
Sandrine Claus Chief Scientific Officer @ LNC Therapeutics
Chief Scientific Officer
2017-01-01

georges-rawadi_image

Georges Rawadi
Georges Rawadi CEO @ LNC Therapeutics
CEO
2018-04-01

Founder


fabrice-guez_image

Fabrice Guez

jean-luc-treillou_image

Jean-Luc Treillou

jerome-theron_image

Jerome Theron

Investors List

seventure-partners_image

Seventure Partners

Seventure Partners investment in Venture Round - LNC Therapeutics

seventure-partners_image

Seventure Partners

Seventure Partners investment in Series C - LNC Therapeutics

aquiti-gestion-aci_image

AQUITI Gestion

AQUITI Gestion investment in Series B - LNC Therapeutics

seventure-partners_image

Seventure Partners

Seventure Partners investment in Series B - LNC Therapeutics

gso-capital-partners_image

Blackstone Credit

Blackstone Credit investment in Series B - LNC Therapeutics

irdi-midi-pyrenees_image

IRDI

IRDI investment in Series B - LNC Therapeutics

Official Site Inspections

http://www.lnctherapeutics.com Semrush global rank: 9.57 M Semrush visits lastest month: 139

  • Host name: 104.21.70.36
  • IP address: 104.21.70.36
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "LNC Therapeutics"

SNC Therapeutics, Inc.

SNC Therapeutics Inc. employs a disruptive drug and nonviral gene delivery platform technology for rational immunotherapy. Our synthetic nanocarriers (SNCs) permit scalable, versatile, and โ€ฆSee details»

LNC Therapeutics - Crunchbase Company Profile & Funding

LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies โ€ฆSee details»

LNC Therapeutics - VentureRadar

Website: https://lnctherapeutics.com. Develops therapeutic innovations utilizing gut microbiome potential, focusing on single strain live biotherapeutic products for obesity, metabolic diseases, โ€ฆSee details»

LNC Therapeutics โ€ข La French Tech Bordeaux

LNC Therapeutics est une société française de biotechnologie spécialisée dans la recherche et le développement de médicaments basés sur le fonctionnement du microbiome intestinal. Fondée en 2010, la société a pour but de développer โ€ฆSee details»

LNC Therapeutics becomes YSOPIA Bioscience - NutraIngredients

Oct 1, 2020 The change comes as the firm received US approval this month for a Phase 1 trial looking into how a live single bacterial strain of Christensenella minuta could be used to โ€ฆSee details»

SNC Therapeutics, Inc. | LinkedIn

SNC Therapeutics Inc. employs a disruptive drug and nonviral gene delivery platform technology for rational immunotherapy. Our synthetic nanocarriers (SNCs) permit scalable, versatile, and ...See details»

LNC Therapeutics Company Information - Funding, Investors, and โ€ฆ

Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»

LNC Therapeutics - Overview, News & Similar companies - ZoomInfo

View LNC Therapeutics (www.lnctherapeutics.com) location in Nouvelle-Aquitaine, France , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

YSOPIA Bioscience (previously LNC Therapeutics) | VentureRadar

Similar Companies: XENO BIOSCIENCES INC. USA Privately Held Xeno Biosciences is a clinical-stage company focused on developing transformational therapies for metabolic โ€ฆSee details»

LNC Therapeutics (Exclusive Worldwide License For Therapeutic ...

Information on acquisition, funding, investors, and executives for LNC Therapeutics (Exclusive Worldwide License For Therapeutic Application Of Christensenella). Use the PitchBook โ€ฆSee details»

LNC Therapeutics - Company info. interviews, news

Founded in 2010, LNC Therapeutics is a French biotech company specialized in gut microbiome-based drug discovery. All of the company's projects include basic research, preclinical research and clinical trials.See details»

lncTAC 2025 Company Profile: Valuation, Funding & Investors

LncTAC General Information Description. Researcher and developer of lncRNA (Long noncoding RNA)-mediated chimeric technology intended for unmet clinical needs. The company develops โ€ฆSee details»

LNC targets human trials this year as it steps up licencing and โ€ฆ

May 7, 2020 French biotech LNC Therapeutics says it will launch the first ever in-human trials to dose with a single strain of Christensenella before the end of 2020, as the company looks to โ€ฆSee details»

LNC Therapeutics forms advisory board for Christensenella research

LNC Therapeutics, a French biotech company specialising in gut microbiome-based drug research and discovery, has formed its Scientific Advisory Board (SAB), composed of โ€ฆSee details»

LNC Therapeutics develops Christensenella therapy for mood

Apr 21, 2020 French biotech firm LNC Therapeutics is to enter into a licence agreement with the University of Valencia for a patent outlining the Christensenella gut bacteria's role in โ€ฆSee details»

LNC Therapeutics - VentureRadar

Similar Companies: Azitra USA Private Azitra, Inc. is a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to โ€ฆSee details»

LNC Therapeutics Licenses Microbiome Therapeutic to Treat Mood โ€ฆ

Apr 17, 2020 The French microbiome biotech LNC Therapeutics has entered into a licensing agreement to use a specific strain of gut bacteria for the treatment of mood disorders such as โ€ฆSee details»

LncRNAs: expanding horizons in drug development and disease โ€ฆ

Feb 15, 2025 Affiliations 1 International School of Medicine, International Institutes of Medicine, The 4th Affiliated Hospital of Zhejiang University School of Medicine, Yiwu 322000, China; โ€ฆSee details»

LNC Therapeutics Gets a Leg Up to Launch it Microbiome โ€ฆ

Sep 28, 2017 The microbiome field is young yet, but itโ€™s an area of great interest in therapeutics. Enterome recently sealed a deal with BMS in immuno-oncology, while Nestlé partnered with โ€ฆSee details»

Snc Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials

Explore Snc Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

linkstock.net © 2022. All rights reserved